Saud Al Sifri

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial

Saud Al Sifri, A. Basiounny, Akram Echtay et al. · International Journal of Clinical Practice · 2011 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +11

Advancing Therapy in Suboptimally Controlled Basal Insulin–Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial

Julio Rosenstock, Rıfat Emral, Leobardo Sauque‐Reyna et al. · Diabetes Care · 2021 · 58 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN

Mohamed Hassanein, Saud Al Sifri, Shehla Shaikh et al. · Diabetes Research and Clinical Practice · 2020 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes

Ronnie Aronson, G. R. Galstyan, Margalit Goldfracht et al. · Diabetes Research and Clinical Practice · 2018 · 29 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

Advancing therapy with <scp>iGlarLixi</scp> versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the <scp>SoliMix</scp> randomized controlled trial

Rory J. McCrimmon, Saud Al Sifri, Rıfat Emral et al. · Diabetes Obesity and Metabolism · 2021 · 28 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +12